Ampliphi Biosciences Corp (
NYSEAMERICAN:APHB -
Get Free Report) rose 1.7% on Tuesday . The company traded as high as $3.13 and last traded at $3.12. Approximately 5,666 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 842,200 shares. The stock had previously closed at $3.07.
Ampliphi Biosciences Price Performance
The stock has a fifty day moving average price of $2.75 and a two-hundred day moving average price of $2.08.
About Ampliphi Biosciences
(
Get Free Report)
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ampliphi Biosciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ampliphi Biosciences wasn't on the list.
While Ampliphi Biosciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
